FundedIQ
Healthcare

Ascilion

Ascilion provides painless extraction and analysis of interstitial fluid with hollow microneedles.

www.ascilion.com Stockholm, Sweden 1-10 employees
Total raised
$2.2M
Rounds
1
Latest
Venture - Series Unknown
Sep 2025

Ascilion provides painless extraction and analysis of interstitial fluid with hollow microneedles.

Ascilion has raised $2.2M across 1 round. Its most recent round was a Venture - Series Unknown of $2.2M in Sep 2025. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with plan

1 round on record.

Date
Round
Amount
Lead investor
Sep 24, 2025
Venture - Series Unknown
$2.2M

Unlock the lead investor and full details for this round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

Ascilion is featured in

Similar companies

Cordance Medical

Cordance Medical develops radical therapy for a variety of CNS pathology.

Seed $8.0M
Bioactivx

Bioactivx is a healthcare firm that accelerates wound recovery, deliver better outcomes for conditions like ulcer, burns and cuts.

Seed $1.4M
DefEYE

DefEYE is an eye care startup that is expanding quickly with the goal of changing and customizing therapeutic procedures.

Seed $12.0M
Pluro Fertility and IVF

Pluro's goal is to create a single national platform for IVF and fertility treatment.

Series A $14.1M
Ki Health

Kihealth is launching the world's first blood test capable of identifying diabetes risk before symptoms emerge.

Seed $5.0M
Garba AI

Garba AI is a business intelligence platform that delivers software to automate the sales process with AI-powered insights.

Pre-Seed $470k
Kovant

Kovant develops an AI agent platform to automate enterprise operations across supply chain, finance, and procurement.

Pre-Seed $1.7M
AlixLabs

AlixLabs provides nanostructure fabrication techniques through the use of the atomic layer etching process. This process is known for its ability to etch without causing damage. AlixLabs offers a method that relies on atomic layer etching to produce nanostructures with sizes smaller than 20 nm. Their technology surpasses the limitations of optical and electron beam lithography in creating nanostructures, making it valuable in the fabrication of nanoelectronic devices. Furthermore, this innovation has the potential to allow for cost-effective scaling of transistor channels in technology nodes below 20 nm.

Series A $16.3M
Spiich Labs

AI sales assistant that eliminates administrative work for revenue teams

Pre-Seed $690k
DREV

DREV offers innovative cleaning technology for battery manufacturing.

Seed $3.2M
Grasp

Grasp is a platform powered by artificial intelligence that has been developed to gather and analyze data on global businesses in order to offer market insights.

Series A $7.0M
Cellcolabs

Cellcolabs is a biotechnology company that production of mesenchymal stromal cells for research and clinical applications.

Venture - Series Unknown $12.0M
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.